SAN DIEGO — Illumina, Inc. (Nasdaq: ILMN), a global leader in DNA sequencing and array-based technologies, confirmed today that it has received notice from Icahn Partners LP and certain of its affiliates of their intention to nominate three candidates—two current Icahn employees, Jesse Lynn and Andrew Teno, and one former Icahn employee, Vincent Intrieri—for election to the Board […]
Semaphore is a leading provider of informatics services and laboratory information management systems (LIMS) supporting life science companies Anthony Uzzo, previously co-founder of Core Informatics and VP of R&D for Digital Science at Thermo Fisher Scientific, to join Semaphore Board as Executive Chairman NEW YORK & VICTORIA, British Columbia — Semaphore Solutions today announced a […]
SOUTH SAN FRANCISCO, Calif. — TeraPore Technologies, the developer of advanced nanofiltration membrane systems for biomanufacturing, today announced it has raised $10M in new financing. The round was led by existing investor Anzu Partners with participation from Entegris (NASDAQ: ENTG), a global leader in advanced materials science, and fellow existing investor, RA Capital Management. TeraPore […]
Following record sales growth and launch of disruptive new product CEDAR PARK, TX — VUV Analytics, Inc. announced today that it has raised $20 million in equity financing—led by existing investors S3 Ventures and New Science Ventures—bringing its total funding to over $36 million. The announcement follows the recent launch of the company’s LUMA product […]
Investment marks Denmark’s largest seed round, funding an integrated hardware and software platform to accelerate discovery, reduce errors and eliminate cumbersome manual experimentation COPENHAGEN, Denmark — Reshape Biotech, an integrated hardware and software platform digitizing microbiology experiments, today announced an $8.1 million investment, Denmark’s largest-ever seed round. The oversubscribed investment was led by ACME Capital, with […]
Oversubscribed round led by Foresite Capital Funding will enable development of DNA synthesis chip technology to commercial scale Cambridge, UK – EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology to DNA synthesis, today announced it has completed a USD $24 million financing round, extending its total series B funding to over USD $54 million […]
Oversubscribed round led by Foresite Capital Funding will enable development of DNA synthesis chip technology to commercial scale CAMBRIDGE, England — EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology to DNA synthesis, today announced it has completed a USD $24 million financing round, extending its total series B funding to over USD $54 […]
Developing synthetic cells for a range of applications in diagnostics and therapeutics EMERYVILLE, Calif. — Slingshot Biosciences, a biotechnology company building the world’s first on-demand synthetic cell platform for customizing cell and cell line mimics, today announced the closing of $11 million in a Series A3 financing. The investment was co-led by ARCH Venture Partners and Northpond Ventures, […]
Funding received from the Bill & Melinda Gates Foundation for rapid deployment of novel detection reagents to support mass scale testing in low to middle-income countries Bedfordshire, UK: MIP Discovery, a leader in rationally designed detection reagents based on its proprietary nanoMIP™ technology, has today announced it has secured a significant grant of funds from the Bill […]
The successful development of the measurement technology specialist from Graz continues: On the one hand, new subsidiaries were founded in the Netherlands and in the Philippines, on the other hand, Anton Paar was also able to achieve a turnover of more than half a billion euros for the first time in the company’s history. With […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
